skip to main content
Resultados 1 2 3 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer

Lin, J.J. ; Liu, S.V. ; McCoach, C.E. ; Zhu, V.W. ; Tan, A.C. ; Yoda, S. ; Peterson, J. ; Do, A. ; Prutisto-Chang, K. ; Dagogo-Jack, I. ; Sequist, L.V. ; Wirth, L.J. ; Lennerz, J.K. ; Hata, A.N. ; Mino-Kenudson, M. ; Nardi, V. ; Ou, S.-H.I. ; Tan, D.S.-W. ; Gainor, J.F.

Annals of oncology, 2020-12, Vol.31 (12), p.1725-1733 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

2
Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions
Material Type:
Artigo
Adicionar ao Meu Espaço

Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions

Piotrowska, Z. ; Costa, D.B. ; Oxnard, G.R. ; Huberman, M. ; Gainor, J.F. ; Lennes, I.T. ; Muzikansky, A. ; Shaw, A.T. ; Azzoli, C.G. ; Heist, R.S. ; Sequist, L.V.

Annals of oncology, 2018-10, Vol.29 (10), p.2092-2097 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

3
Acquired Resistance to Afatinib in EGFR-Mutant Lung Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Acquired Resistance to Afatinib in EGFR-Mutant Lung Cancer

Sequist, L.V ; Gerber, D.E ; Fidias, P ; Shaw, A.T ; Temel, J.S ; Heist, R.S ; Gainor, J.F ; Fulton, L ; Kennedy, E.A ; Muzikansky, A ; Engelma, J.A

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S43-S44 [Periódico revisado por pares]

Texto completo disponível

4
Variation in Mechanisms of Acquired Resistance Among EGFR-Mutant NSCLC Patients With More Than 1 Postresistant Biopsy
Material Type:
Artigo
Adicionar ao Meu Espaço

Variation in Mechanisms of Acquired Resistance Among EGFR-Mutant NSCLC Patients With More Than 1 Postresistant Biopsy

Piotrowska, Z ; Niederst, M.J ; Mino-Kenudson, M ; Morales-Oyarvide, V ; Fulton, L ; Lockerman, E ; Howe, E ; Gainor, J.F ; Fidias, P ; Heist, R.S ; Shaw, A.T ; Engelman, J.A ; Sequist, L.V

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S6-S7 [Periódico revisado por pares]

Texto completo disponível

5
Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer: Significance of Mutations in EGFR, ALK, or KRAS on Radiation Therapy Response and Survival
Material Type:
Artigo
Adicionar ao Meu Espaço

Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer: Significance of Mutations in EGFR, ALK, or KRAS on Radiation Therapy Response and Survival

Mak, K.S ; Gainor, J.F ; Niemierko, A ; Oh, K.S ; Willers, H ; Choi, N.C ; Loeffler, J.S ; Sequist, L.V ; Shaw, A.T ; Shih, H.A

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S51-S51 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

6
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
Material Type:
Artigo
Adicionar ao Meu Espaço

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

Aguilar, E.J. ; Ricciuti, B. ; Gainor, J.F. ; Kehl, K.L. ; Kravets, S. ; Dahlberg, S. ; Nishino, M. ; Sholl, L.M. ; Adeni, A. ; Subegdjo, S. ; Khosrowjerdi, S. ; Peterson, R.M. ; Digumarthy, S. ; Liu, C. ; Sauter, J. ; Rizvi, H. ; Arbour, K.C. ; Carter, B.W. ; Heymach, J.V. ; Altan, M. ; Hellmann, M.D. ; Awad, M.M.

Annals of oncology, 2019-10, Vol.30 (10), p.1653-1659 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

7
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research
Material Type:
Artigo
Adicionar ao Meu Espaço

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research

Belli, C. ; Penault-Llorca, F. ; Ladanyi, M. ; Normanno, N. ; Scoazec, J.-Y. ; Lacroix, L. ; Reis-Filho, J.S. ; Subbiah, V. ; Gainor, J.F. ; Endris, V. ; Repetto, M. ; Drilon, A. ; Scarpa, A. ; André, F. ; Douillard, J.-Y. ; Curigliano, G.

Annals of oncology, 2021-03, Vol.32 (3), p.337-350 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

8
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

Hellmann, M.D. ; Kim, T.-W. ; Lee, C.B. ; Goh, B.-C. ; Miller, W.H. ; Oh, D.-Y. ; Jamal, R. ; Chee, C.-E. ; Chow, L.Q.M. ; Gainor, J.F. ; Desai, J. ; Solomon, B.J. ; Das Thakur, M. ; Pitcher, B. ; Foster, P. ; Hernandez, G. ; Wongchenko, M.J. ; Cha, E. ; Bang, Y.-J. ; Siu, L.L. ; Bendell, J.

Annals of oncology, 2019-07, Vol.30 (7), p.1134-1142 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

9
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50
Material Type:
Artigo
Adicionar ao Meu Espaço

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50

Gainor, J.F. ; Rizvi, H. ; Jimenez Aguilar, E. ; Skoulidis, F. ; Yeap, B.Y. ; Naidoo, J. ; Khosrowjerdi, S. ; Mooradian, M. ; Lydon, C. ; Illei, P. ; Zhang, J. ; Peterson, R. ; Ricciuti, B. ; Nishino, M. ; Zhang, J. ; Roth, J.A. ; Grishman, J. ; Anderson, D. ; Little, B.P. ; Carter, B.W. ; Arbour, K. ; Sauter, J.L. ; Mino-Kenudson, M. ; Heymach, J.V. ; Digumarthy, S. ; Shaw, A.T. ; Awad, M.M. ; Hellmann, M.D.

Annals of oncology, 2020-03, Vol.31 (3), p.404-411 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

10
Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

Griesinger, F. ; Curigliano, G. ; Thomas, M. ; Subbiah, V. ; Baik, C.S. ; Tan, D.S.W. ; Lee, D.H. ; Misch, D. ; Garralda, E. ; Kim, D.-W. ; van der Wekken, A.J. ; Gainor, J.F. ; Paz-Ares, L. ; Liu, S.V. ; Kalemkerian, G.P. ; Houvras, Y. ; Bowles, D.W. ; Mansfield, A.S. ; Lin, J.J. ; Smoljanovic, V. ; Rahman, A. ; Kong, S. ; Zalutskaya, A. ; Louie-Gao, M. ; Boral, A.L. ; Mazières, J.

Annals of oncology, 2022-11, Vol.33 (11), p.1168-1178 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (24)

Data de Publicação 

De até
  1. Antes de2014  (2)
  2. 2014Até2016  (5)
  3. 2017Até2018  (4)
  4. 2019Até2021  (12)
  5. Após 2021  (3)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.